Back to top
more

VanEck Biotech ETF: (BBH)

(Delayed Data from NASDAQ) As of Jun 9, 2026 03:57 PM ET

$187.51 USD

187.51
3,885

+1.46 (0.78%)

Volume: 3,885

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

Zacks News

Sweta Jaiswal, FRM headshot

How Are Biotech ETFs Reacting to These Q4 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Sanghamitra Saha headshot

Omicron Vaccines to Hit Market Soon? ETF Areas to Benefit

Pfizer is likely to launch Omicron vaccine in March while Moderna is working on a booster that targets the omicron variant of Covid-19.

Zacks Equity Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

Sanghamitra Saha headshot

Top ETF Stories of November

The emergence of the Omicron variant of Covid-19 and inflationary pressure were key highlights of the broader market in November.

Sweta Jaiswal, FRM headshot

Moderna ETFs Rallying on COVID-19 Vaccine News to Combat Omicron

Moderna has been rallying amid concerns surrounding the omicron variant, which has led to possibilities of a rise in demand for COVID-19 vaccines and boosters.

Sanghamitra Saha headshot

ETF Areas to Gain/Lose on Fear of Omicron Strain of Coronavirus

The emergence of a new coronavirus strain, namely Omicron, has caused a massacre on Wall Street on Friday. These ETFs could gain/lose in the coming days if Omicron cases continue to rise.

Sweta Jaiswal, FRM headshot

Moderna ETFs to Rally on Positive COVID-19 Booster Shot News

Moderna is expected to gain approval for booster shots for its COVID-19 vaccine.

Zacks Equity Research

Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

Sweta Jaiswal, FRM headshot

How Are Biotech ETFs Reacting to These Q3 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

Sweta Jaiswal, FRM headshot

Can Biotech ETFs Gain From Positive Booster Update?

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.